Serena Colafrancesco

Serena Colafrancesco

Auto-generated profile, based on publicly available information

Serena Colafrancesco

Division of Rheumatology, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University, 00133 Rome, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Journal of Autoimmunity
Verified
Journal Article
Closed access
Carlo PerriconeCarlo Perricone
Carlo Perricone
SCSerena Colafrancesco
Serena Colafrancesco
RMRoei D. Mazor
Roei D. Mazor
ASAlessandra Soriano
Alessandra Soriano
NANancy Agmon-Levin
Nancy Agmon-Levin
YSYehuda Shoenfeld
Yehuda Shoenfeld

1 July 2014 in Autoimmunity Reviews
Verified
Journal Article
Closed access
RCRicard Cervera
Ricard Cervera
IRIgnasi Rodríguez-Pintó
Ignasi Rodríguez-Pintó
SCSerena Colafrancesco
Serena Colafrancesco
FCFabrizio Conti
Fabrizio Conti
GVGuido Valesini
Guido Valesini
GEGerard Espinosa
Gerard Espinosa

12 September 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
EPElena Pipi
Elena Pipi
SNSaba Nayar
Saba Nayar
DGDavid H. Gardner
David H. Gardner
SCSerena Colafrancesco
Serena Colafrancesco
CSCharlotte Smith
Charlotte Smith
FBFrancesca Barone
Francesca Barone
Tertiary lymphoid structures (TLS) are frequently observed in target organs of autoimmune diseases. TLS present features of secondary lymphoid organs such as segregated T and B cell zones, presence of follicular dendritic cell networks, high endothelial venules and specialized lymphoid fibroblasts and display the mechanisms to support local adaptive immune responses toward locally displayed antigens. TLS detection in the tissue is often associated with poor prognosis of disease, auto-antibody production and malignancy development. This review focuses on the contribution of TLS toward the persistence of the inflammatory drive, the survival of autoreactive lymphocyte clones and post-translational modifications, responsible for the pathogenicity of locally formed autoantibodies, during autoimmune disease development.

1 December 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
EPElena Pontarini
Elena Pontarini
WMWilliam James Murray-Brown
William James Murray-Brown
CCCristina Croia
Cristina Croia
DLDavide Lucchesi
Davide Lucchesi
JCJames Conway
James Conway
MBMichele Bombardieri
Michele Bombardieri
Objectives To explore the relevance of T-follicular-helper (Tfh) and pathogenic peripheral-helper T-cells (Tph) in promoting ectopic lymphoid structures (ELS) and B-cell mucosa-associated lymphoid tissue (MALT) lymphomas (MALT-L) in Sjögren’s syndrome (SS) patients. Methods Salivary gland (SG) biopsies with matched peripheral blood were collected from four centres across the European Union. Transcriptomic (microarray and quantitative PCR) analysis, FACS T-cell immunophenotyping with intracellular cytokine detection, multicolor immune-fluorescence microscopy and in situ hybridisation were performed to characterise lesional and circulating Tfh and Tph-cells. SG-organ cultures were used to investigate functionally the blockade of T-cell costimulatory pathways on key proinflammatory cytokine production. Results Transcriptomic analysis in SG identified Tfh-signature, interleukin-21 (IL-21) and the inducible T-cell co-stimulator (ICOS) costimulatory pathway as the most upregulated genes in ELS+SS patients, with parotid MALT-L displaying a 400-folds increase in IL-21 mRNA. Peripheral CD4+CXC-motif chemokine receptor 5 (CXCR5)+programmed cell death protein 1 (PD1)+ICOS+ Tfh-like cells were significantly expanded in ELS+SS patients, were the main producers of IL-21, and closely correlated with circulating IgG and reduced complement C4. In the SG, lesional CD4+CD45RO+ICOS+PD1+ cells selectively infiltrated ELS+ tissues and were aberrantly expanded in parotid MALT-L. In ELS+SG and MALT-L parotids, conventional CXCR5+CD4+PD1+ICOS+Foxp3- Tfh-cells and a uniquely expanded population of CXCR5-CD4+PD1hiICOS+Foxp3- Tph-cells displayed frequent IL-21/interferon-γ double-production but poor IL-17 expression. Finally, ICOS blockade in ex vivo SG-organ cultures significantly reduced the production of IL-21 and inflammatory cytokines IL-6, IL-8 and tumour necrosis factor-α (TNF-α). Conclusions Overall, these findings highlight Tfh and Tph-cells, IL-21 and the ICOS costimulatory pathway as key pathogenic players in SS immunopathology and exploitable therapeutic targets in SS.

1 June 2014 in Journal of Autoimmunity
Verified
Journal Article
Closed access
Luca QuartuccioLuca Quartuccio
Luca Quartuccio
MIMiriam Isola
Miriam Isola
CBChiara Baldini
Chiara Baldini
RPRoberta Priori
Roberta Priori
RGRoberto Gerli
Roberto Gerli
SVSalvatore De Vita
Salvatore De Vita

1 November 2015 in Autoimmunity Reviews
Verified
Journal Article
Closed access
Luca QuartuccioLuca Quartuccio
Luca Quartuccio
CBChiara Baldini
Chiara Baldini
RGRoberto Gerli
Roberto Gerli
RPRoberta Priori
Roberta Priori
FCFrancesco Carubbi
Francesco Carubbi
SVSalvatore De Vita
Salvatore De Vita